IP Verse

Merck competitive analysis

Loading summary...

Latest oppositions filed by Merck

Explore patent oppositions filed by Merck against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4241767
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025
EP4200443
A Method For The Isolation Of Double-Strand BreaksUNIVERSITY COLLEGE CARDIFF CONSULTANTSJan 9, 2025
EP3597659
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023
EP3887452
Radar Frequency Transparent Effect Pigment Mixture, Formulations And Coatings ThereofECKARTAug 2, 2023
EP3822717
Method And Device Assembly For Predicting A Parameter In A Bioprocess Based On Raman Spectroscopy And Method And Device Assembly For Controlling A BioprocessSARTORIUS STEDIM DATA ANALYTICSJun 7, 2023
EP3597216
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSApr 27, 2023
EP3760715
Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMay 4, 2022
EP3604296
Organic Light Emitting Element And Composition For Organic Material Layer In Organic Light Emitting ElementHEESUNG MATERIALApr 27, 2022
EP3611173
Organic Light Emitting Element And Composition For Organic Material Layer In Organic Light Emitting ElementHEESUNG MATERIALApr 27, 2022
EP3623444
Organic Electroluminescent Devices And Metal Complex CompoundsUDC IRELANDFeb 22, 2022

Latest patents of Merck opposed by its competitors

Explore Merck's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3378900
Mar 5, 2025Pigment Powders1
EP3165220
Nov 13, 2024Pharmaceutical Composition Containing An Anti-Nucleating Agent2
EP3616695
Oct 23, 2024Methods For Treating Intrapulmonary Infections1
EP3283882
Oct 16, 2024Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists1
EP4070800
Oct 16, 2024Cladribine Regimen For Treating Multiple Sclerosis1
EP3678654
Jun 26, 2024Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates3
EP3457450
Jun 12, 2024Organic Electroluminescent Device1
EP1841493
May 29, 2024Applicator For Inserting An Implant1
EP3210248
Apr 10, 2024Materials For Electronic Devices1
EP3328841
Oct 11, 2023Materials For Organic Electroluminescent Devices1

Latest publications and patents of Merck New

Explore the latest publications and patents granted to Merck, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merck

EP4603562
Aug 20, 2025Spirobifluorene Derivatives For Use In Electronic DevicesPending
EP4601694
Aug 20, 2025Compositions And Methods For Treating Cancer With Subcutaneous Administration Of Anti-Pd1 AntibodiesPending
EP4601693
Aug 20, 2025Compositions And Methods For Treating Cancer With Subcutaneous Administration Of Anti-Pd1 AntibodiesPending
EP4373849
Aug 20, 2025Il-2 Muteins For Treating Cancer Or InfectionPending
EP4244616
Aug 20, 2025Method For Evaluation Of A Thin-Layer Chromatography PlateGranted
EP4168397
Aug 20, 2025IndenoazanaphthalenesGranted
EP3693082
Aug 20, 2025Disc-Shaped Porous Support Member For A Filter MembraneGranted
EP4597237
Aug 6, 2025Generation Of Customized Software Based Models For Production Process ApplicationsPending
EP4594743
Aug 6, 2025An Analytical Method Using Lc-Ms/Ms Proteomics To Characterize Proteins Translated From MrnaPending
EP4594290
Aug 6, 2025Metal Complex And Formulation For The Preparation Of Metal Oxide Optical LayersPending

Latest PTAB cases involving Merck

Discover the latest PTAB cases involving Merck, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 27, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merck

PGR2025-00052Jun 27, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00053Jun 6, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00050May 7, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00046Apr 29, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00042Apr 15, 2025MERCK SHARP & DOHMEHALOZYMEPreliminary response waived
PGR2025-00039Mar 28, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00033Mar 7, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00024Feb 21, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00030Feb 4, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted
PGR2025-00017Jan 17, 2025MERCK SHARP & DOHMEHALOZYMETrial Instituted

Peer Comparison New

IP litigation analysis comparing Merck with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERCK PATENT3425 - -
JNC13 - 1
JNC PETROCHEMICAL - 3 - -
NIPPON STEEL CHEMICAL & MATERIAL31 - -